Podcast Episodes

Back to Search
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC

Episode 182

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontlin…

1 year, 7 months ago

Short Long
View Episode
ROS1-Alterations and Molecular Testing in Advanced NSCLC
ROS1-Alterations and Molecular Testing in Advanced NSCLC

Episode 181

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements i…

1 year, 7 months ago

Short Long
View Episode
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers

Episode 180

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data present…

1 year, 8 months ago

Short Long
View Episode
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Episode 179

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest d…

1 year, 8 months ago

Short Long
View Episode
Current Clinical Practice and NCCN Guidelines for CLL/SLL
Current Clinical Practice and NCCN Guidelines for CLL/SLL

Episode 178

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align curr…

1 year, 8 months ago

Short Long
View Episode
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs

Episode 177

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented …

1 year, 9 months ago

Short Long
View Episode
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

Episode 176

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:

Rationale for ta…

1 year, 9 months ago

Short Long
View Episode
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Episode 175

In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest dat…

1 year, 9 months ago

Short Long
View Episode
Congress to Clinic: Expert Takeaways on Emerging Data for AML
Congress to Clinic: Expert Takeaways on Emerging Data for AML

Episode 174

In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) prese…

1 year, 9 months ago

Short Long
View Episode
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
Congress to Clinic: Expert Takeaways on Emerging Data for MDS

Episode 173

In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic…

1 year, 9 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us